FindTrial
Sign In

USE OF CITICOLINE DRUG IN TREATMENT OF AMBLYOPIA .OR LAZY EYE ASSOCIATED WITH IMPAIRED VISION

EFFECTIVENESS OF CITICOLINE AS ADJUVANT THERAPY TO PATCHING IN THE MANAGEMENT OF AMBLYOPIA : RCT - RCT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/09/015653
Enrollment
80
Registered
2018-09-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H479- Unspecified disorder of visual pathways

Interventions

Intervention1: CITICOLINE: CITICOLINE IS AN INTERMEDIATE IN THE GENERATION OF PHOSPHATIDYLCHOLINE FROM CHOLINE .ITS USES ARE MEMORY AND COGNITION , ISCHEMIC STROKE ,VISION ETC Control Intervention1: P

Sponsors

VISHAL DEV
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS WITH ANISOMETROPIC AND STRABISMIC AMBLYOPIA . MODERATE AMBLYOPIA 6/60 to 6/18 .

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
UCVA BCVA CYCLOPLEGIC REFRACTION DISTANCE STEREOACUITY NEAR STEREOACUITY COLOR VISION SIDE EFFECTSTimepoint: 1,2,3,4,6 MONTHS—

Secondary

MeasureTime frame
UCVA BCVA Cycloplegic refractionTimepoint: AT 6 MONTHS—

Countries

India

Contacts

Public ContactVISHAL DEV

AIIMS

rohitsaxena80@yahoo.com9868155230

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026